Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TECOGEN INC.TGEN · Entity 6846 | Director | June 23, 2022 | June 28, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TECOGEN INC.
Report date June 23, 2022 · Filed June 28, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.20 · Expires 2032-06-23 | Direct | 150,000 |
Reported balance
After 2022-06-23 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-06-23 · Grant · Acquired 25,000 · Balance 150,000 F1: Vests 25% per year |
Filing footnotes · ownership attribution and instrument terms
F1: Vests 25% per year
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 23, 2022 Filed Jun 28, 2022 22:32 UTC | TECOGEN INC. TGEN · Entity 6846 | GrantStock Option (Right to Buy) · Derivative | 25,000 | $1.20 Strike: $1.20 | $30,000.00 |
DisclosureSEC source: 0001537435-22-000078 · wf-form4_165645553564151.xml · derivative · entry 1 Jenkins Ralph · CIK 0001917530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 25,000 shares Expires 2032-06-23 F1 · derivative.exercise_date: Vests 25% per year Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.